SIE
Click for more information
0.00% 6.8¢ scigen limited

interest-in-biosimilars

  1. adder
    520 Posts.
    clock Created with Sketch.
    17/09/10
    09:42
    Post #: 7209328
    http://pharmtech.findpharma.com/pharmtech/News/Actavis-Signals-Interest-in-Biosimilars-Market/ArticleStandard/Article/detail/687077?contextCategoryId=35097
    SIE Price at posting: 25.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
NEWS Talking Australia's very competitive property landscape: Realty Talks
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SIE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.